126 related articles for article (PubMed ID: 30317847)
1.
Demirev AK; Kostadinova ID; Gabrovski IR
Mol Imaging Radionucl Ther; 2018 Oct; 27(3):107-112. PubMed ID: 30317847
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3.
Zhang Y; Yu Y; Yu J; Fu Z; Liu T; Guo S
Oncol Lett; 2015 Nov; 10(5):2909-2914. PubMed ID: 26722262
[TBL] [Abstract][Full Text] [Related]
4. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy.
Jahangiri P; Pournazari K; Torigian DA; Werner TJ; Swisher-McClure S; Simone CB; Alavi A
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):206-216. PubMed ID: 30229527
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Functional Lung Heterogeneity and Dosimetry to Radiation Pneumonitis using Perfusion SPECT/CT and FDG PET/CT Imaging.
Lee HJ; Zeng J; Vesselle HJ; Patel SA; Rengan R; Bowen SR
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1255-1264. PubMed ID: 30108002
[TBL] [Abstract][Full Text] [Related]
7. [18F]2-fluoro-2-deoxyglucose positron emission tomography/computed tomography in predicting radiation pneumonitis.
Song H; Yu JM; Kong FM; Lu J; Bai T; Ma L; Fu Z
Chin Med J (Engl); 2009 Jun; 122(11):1311-5. PubMed ID: 19567143
[TBL] [Abstract][Full Text] [Related]
8. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
9. PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessment.
Iravani A; Turgeon GA; Akhurst T; Callahan JW; Bressel M; Everitt SJ; Siva S; Hofman MS; Hicks RJ; Ball DL; Mac Manus MP
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1869-1877. PubMed ID: 31190177
[TBL] [Abstract][Full Text] [Related]
10. Long-term Trace of Radiation Pneumonitis With 18F-Fluoroestradiol.
Morel A; Maucherat B; Chiavassa S; Kraeber-Bodéré F; Rousseau C
Clin Nucl Med; 2020 Sep; 45(9):e403-e405. PubMed ID: 32657871
[TBL] [Abstract][Full Text] [Related]
11. Pre-Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis.
Castillo R; Pham N; Castillo E; Aso-Gonzalez S; Ansari S; Hobbs B; Palacio D; Skinner H; Guerrero TM
Radiology; 2015 Jun; 275(3):822-31. PubMed ID: 25584706
[TBL] [Abstract][Full Text] [Related]
12. High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer.
Calais J; Dubray B; Nkhali L; Thureau S; Lemarignier C; Modzelewski R; Gardin I; Di Fiore F; Michel P; Vera P
Eur J Nucl Med Mol Imaging; 2015 May; 42(6):858-67. PubMed ID: 25680400
[TBL] [Abstract][Full Text] [Related]
13. Differences in lung injury after IMRT or proton therapy assessed by
Shusharina N; Liao Z; Mohan R; Liu A; Niemierko A; Choi N; Bortfeld T
Radiother Oncol; 2018 Jul; 128(1):147-153. PubMed ID: 29352608
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study.
Yue J; Shi Q; Xu T; Jeter M; Chen TY; Komaki R; Gomez DR; Pan T; Cleeland CS; Liao Z; Wang XS
Qual Life Res; 2018 Jun; 27(6):1563-1570. PubMed ID: 29549533
[TBL] [Abstract][Full Text] [Related]
15. Use of
Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E
Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718
[No Abstract] [Full Text] [Related]
16. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
17. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).
Chaudhuri AA; Binkley MS; Rigdon J; Carter JN; Aggarwal S; Dudley SA; Qian Y; Kumar KA; Hara WY; Gensheimer M; Nair VS; Maxim PG; Shultz DB; Bush K; Trakul N; Le QT; Diehn M; Loo BW; Guo HH
Radiother Oncol; 2016 Jun; 119(3):454-60. PubMed ID: 27267049
[TBL] [Abstract][Full Text] [Related]
18. Characterization of thymic masses using (18)F-FDG PET-CT.
Kumar A; Regmi SK; Dutta R; Kumar R; Gupta SD; Das P; Halanaik D; Jindal T
Ann Nucl Med; 2009 Aug; 23(6):569-77. PubMed ID: 19585212
[TBL] [Abstract][Full Text] [Related]
19. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of metabolic parameters measured by
Chang H; Lee SJ; Lim J; Lee JS; Kim YJ; Lee WW
J Cancer Res Clin Oncol; 2019 May; 145(5):1361-1367. PubMed ID: 30900157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]